Providing recurrence numbers is often considered a fundamental component of genetic counseling. We sought to fill knowledge gaps regarding how often patients actively seek recurrence numbers, and how they impact patient outcomes. We conducted a retrospective chart review at a clinic where patients routinely complete the Genetic Counseling Outcomes Scale (GCOS, measuring empowerment) pre (T1)/post (T2) appointment. Using analysis of covariance, we evaluated the effect on T2 GCOS score of: (1) receiving recurrence numbers and (2) patient perception of recurrence numbers. Recurrence numbers were a primary indication for 134/300 patients (45%). After counseling about etiology and risk-reducing strategies, 116 patients (39%) opted to receive recurrence numbers, with most (n = 64, 55%) perceiving the number to be lower than expected. There was no difference in T2 GCOS scores between those who:
implicit assumptions that patients seeking or being referred to genetic counseling are motivated by a desire to know recurrence numbers, there are limited substantiating data on this topic. 4 Studies have examined patients' naturally pre-existing estimations of numerical probabilities for disease recurrence, and explored how objective probabilistic information affects their perceptions. [5] [6] [7] [8] However, despite increasing recognition of the importance of research focused on the impact of clinical genetics services on patient outcomes, there have been limited studies on how risk communication and perception impacts patient outcomes of genetic counseling.
Therefore, in the context of a psychiatric genetic counseling clinic, we sought to investigate how often recurrence numbers constitute a primary indication for referral, and how often patients ultimately choose to receive these numbers. We also aimed to explore how receiving recurrence numbers influenced patient outcomes by testing the hypotheses that greater increases in empowerment after genetic counseling would be observed among patients who: (1) received recurrence numbers during their genetic counseling appointment (as compared to those who did not) (hypothesis 1), and (2) perceived the recurrence numbers they received to be lower than anticipated (as compared to patients who had other perceptions of the number they received) (hypothesis 2).
| MATERIALS AND METHODS
Although this study was conducted in the context of naturalistic clinical practice, rather than as an intervention study, we have opted to use the reporting standards for genetic counseling research as outlined by Hooker et al 9 (see Appendix S1, Supporting Information, for checklist).
| Clinical context
We conducted a retrospective chart review study using data from a specialist psychiatric genetic counseling clinic (The Adapt Clinic) based in Vancouver, BC, where 2 board certified counselors provide services to people with a personal or family history of a psychiatric disorder (structure, content, and mode of delivery of sessions is described in Inglis et al 4 ) . Clinic patients routinely complete the Genetic Counseling
Outcomes Scale (GCOS, see below) as a clinical assessment/contracting tool at the beginning of their genetic counseling session (T1), and complete it again via phone administration by the genetic counselor at 1-month follow-up (T2).
Previous research conducted in this clinic has demonstrated higher levels of patient empowerment and self-efficacy following the genetic counseling appointment. 4, 10 In the psychiatric genetic counseling context, there are no interventions, referrals or procedures that are contingent on patient knowledge of recurrence numbers, and thus their disclosure can be driven by patient preference. Our clinical experience reveals that after counseling about: the complex etiology of psychiatric illness; general discussion of how we all have some genetic vulnerability to mental illness, but that generally individual genetic variants are neither necessary or sufficient for psychiatric illness; and strategies for protecting mental health/reducing risk, patients may decide to not receive recurrence numbers. Therefore, routine clinical practice honors this experience, and (as described in Inglis et al 11 ) the counselor contracts with patients about desire for numbers both before and after a fulsome discussion of these other issues. Given that there are no clinical guidelines suggesting the use of genetic testing to estimate the probability of psychiatric illness onset (outside of the context of a known or suspected genetic syndrome), when recurrence numbers are requested, they are typically generated based on empiric data and analysis of a detailed, 3-generation psychiatric family history (as described by Austin et al 12 )
, and provided in the form of absolute risks/frequencies in the context of population rates. 
| Data collection

| Inclusion criteria
All patients seen between February 1, 2012 (the clinic's inception) and February 28, 2017, who had completed the GCOS at both T1 and T2, and who had complete demographic/referral data were included in the study.
| Instrument
GCOS is a 24 item, 7-point Likert scale-based questionnaire that measures empowerment, 14 defined as "a set of beliefs that enable a person from a family affected by a genetic condition to feel that they have some control over and hope for the future." 15 The score of this scale can range from 24 to 168, with higher scores indicating higher levels of empowerment. The GCOS was developed and validated for use in clinical genetics settings and has high internal consistency (α = .87) and test-retest reliability (r = 0.86). 14 GCOS scores were calculated according to instrument-specific instructions.
| Study groups
To test hypothesis 1, regarding whether or not changes in empowerment (as measured by GCOS scores) arising from genetic counseling were related to receiving a recurrence number, we first divided our cohort into 2 groups representing patients who (1) received and (2) did not receive recurrence numbers. Then, for a secondary subanalysis, these groups were subdivided as followed: (1) To test hypothesis 2, regarding the relationship between patients' perceptions of recurrence numbers and change in level of empowerment (as measured by GCOS score), we divided our cohort into 2 groups: (1) those who perceived the number they received to be lower than expected, and (2) those who had other perceptions of the recurrence number they received.
| Analyses
We applied descriptive statistics to the demographic data and the research questions about how often recurrence numbers constitute a primary indication, and how often patients ultimately choose to receive these numbers.
To test differences in patient outcomes between groups who did, and did not receive recurrence numbers, we used analysis of covariance (ANCOVA) on post-appointment (T2) GCOS scores, using baseline (T1) scores as the covariate. We used the same approach to test differences in patient outcomes between the group who perceived recurrence numbers to be lower than anticipated, and the group that included patients with all other perceptions of the number they were
given. Where appropriate, significant findings were further explored with Tukey's post hoc tests and analysis of variance (ANOVA). To contextualize data, paired sample t tests, and standard multiple regression were used to explore the relationship of patient age and T2 GCOS scores.
Statistical significance was assumed at P < .01 after Bonferroni ) would require a sample of N = 115 to achieve 80% power.
3 | RESULTS
| Recurrence numbers: frequency of indication and uptake
In total, 300 patients met our inclusion criteria (demographic data are shown in Table 1 ).
Recurrence numbers constituted a referral indication for 134 patients (45%), making it the second most common indication for the appointment (see Table 2 ).
Ultimately, recurrence numbers were received by 116 patients (39%), with 54 patients' (18%) decisions about receiving recurrence numbers differing from the initial indication for the appointment (see Figure 1 ).
| Effect of receiving recurrence numbers on empowerment
There were no significant differences in T2 GCOS scores between those who did and those who did not receive recurrence numbers after controlling for T1 score (F(1,297) = 2.016, P = .157, small effect
In our secondary analysis, we repeated the ANCOVA using 4 study 
| Impact of perception of recurrence numbers on empowerment
When recurrence numbers were provided, the majority of the patients perceived the number that they received as being lower than b Standardized multiple regression showed that age did not have a significant impact on Genetic Counseling Outcomes Scale (GCOS) T2 scores (P = .235).
expected (Table 3) . After controlling for T1 GCOS score, there were no significant differences in T2 GCOS scores between those individuals who perceived the number as lower than expected, and those who had other perceptions (ie, higher, the same as expected, or did not know what to expect) of the recurrence number (P = .796, F
(1,113) = 0.067, small effect size, η 2 = 0.001).
As a secondary strategy, we repeated the analysis with 4 groups (representing each of the different perceptions individually: higher, the same as expected, or did not know what to expect, see Table 3 ), and found no statistically significant differences between any of the groups (all P > .01).
| Contextual data
A total of 627 patients were seen at the Adapt Clinic within the study time frame. Of these, 311 (50%) completed the GCOS at both T1 and T2. An additional 11 patients were excluded due to incomplete demographic or referral information.
There were statistically significant increases in GCOS scores from T1 to T2 for those who: did receive numbers, did not receive recurrence numbers (both P < .001, see Figure 2 ), perceived the recurrence number received to be lower than expected, or had other perceptions of the number they received (both P < .001, see Table 3 ). As well, there were statistically significant increases in GCOS scores for the sample as a whole (average T1 GCOS score = 111.44, average T2 GCOS score = 126.85; P < .001, η 2 = 0.663, large effect size).
Demographic characteristics were similar to each other between study groupings, aside from age, which was significantly different between those who received and those who did not receive numbers (see Table 1 ). Despite this, standard multiple regression revealed no significant relationship between age and T2 GCOS scores (age accounted for 0.47% of the variance of T2 GCOS score [P = .235]).
The largest predictor of T2 scores was T1 scores, which accounted for 49.6% of the variance (P < .005). The decision to receive recurrence numbers or not accounted for 1.3% of the variance of T2 GCOS scores and was not statistically significant (P = .049).
| DISCUSSION
We present the first data regarding how often patients request recurrence numbers, and how receiving numbers impacts patient outcomes in a psychiatric genetic counseling context. In this study population, discussion of recurrence numbers constituted the second most common indication for genetic counseling. 19 In an earlier study in this same clinic, discussion of recurrence numbers was the most common indication for genetic counseling, this suggests that reasons for referral are evolving. 4 Importantly, after counseling regarding the complex etiology of psychiatric disorders, and risk reduction strategies, fewer than half of all patients receiving psychiatric genetic counseling opted to discuss specific recurrence numbers with nearly 1 in 5 patients (18%) ultimately making a decision about this that differed from the initial indication for referral and/or desire expressed during initial contracting.
This highlights the dynamic nature of the process of contracting to develop a shared understanding of goals and topics for the sessionrather than being a discrete task that is accomplished at the beginning 
n T2 =184 (61%) FIGURE 1 Patients' interest in recurrence numbers at different time points across the genetic counseling process: initial contracting (ie, indication for referral and/or interest expressed by the patient during initial, general contracting, which occurs routinely at the outset of the session), and during risk communication-specific contracting (which occurs routinely after counseling about etiology) of the genetic counseling session, it may be important to revisit assumptions and desires about session content as it unfolds and evolves to ensure a patient-centred focus.
Given the assumptions about the integral nature of risk communication to the genetic counseling encounter, we hypothesized that the provision of recurrence numbers would associate with greater increases in patient empowerment. However, our data supported no such relationship. Even when patients perceived the recurrence numbers that they received to be high-all patients, including those who did, and those who did not receive recurrence numbers-demonstrated large increases in GCOS scores. One possible explanation for this observation is that providing recurrence numbers may not be as fundamentally important to genetic counseling as originally speculated-at least from the perspective of patient reported outcomes-the increased empowerment observed after genetic counseling is unrelated to the provision of recurrence numbers, or to the patients' perceptions of the number provided. Indeed, even patients who perceived the recurrence numbers that they received to be higher than expected demonstrated significant increases in empowerment.
We found significantly greater increases in empowerment after genetic counseling among those who decided to not receive recurrence numbers despite it being an initial indication for the appointment (Y/N), compared to those for whom recurrence numbers were not a primary indication, and did not receive them (N/N). Given the current study for patients who did and did not receive recurrence numbers. The yaxis scale reflects the range of possible scores. Scores increased significantly for both groups between T1 (P < .001) and T2 (P < .001).
After controlling for T1 score, there was no difference in T2 GCOS score between groups who did and did not receive numbers (P = .157) 
| Limitations
This was a naturalistic study based on a convenience sample, and so was influenced by the same factors that shape the population served by the clinic. As a result, our study population was enriched for women, and individuals of European background. Our findings may not be generalizable beyond the psychiatric genetic counseling population-although this is an issue worthy of future study. Although our overall sample size was relatively large, we had smaller sample sizes for some of our subgroups. The unequal sample sizes when analyzing the 4 groups in the secondary analyses may have underestimated the possibility of a type 1 error.
Our sample size places the current study among the largest ever conducted to explore the impact of genetic counseling on patient outcomes, 20 and provided good power to detect the differences between groups of moderate effect size (that can be used to approximate differences of clinically significant magnitude). Post hoc calculations using observed (very small) effect sizes revealed that a sample size of N = 1550 would be required for adequate power to detect the effects of receiving recurrence numbers and perception of recurrence numbers on patient empowerment. A reasonable interpretation of this is that: (1) provision of recurrence numbers and (2) perception of numbers have effects on patient outcomes that are so small as to render the effects of these variables on the outcome of interest clinically meaningless.
It is possible that the groups of patients in whom we tested our hypotheses are different in some way that confounds hypothesis interpretation. However, the groups were demographically similar, with the exception of age among those who did and did not ultimately receive a recurrence number-with those receiving numbers being younger (probably reflecting the patients who were family planning and wanted to discuss recurrence numbers in a preconception setting). Given that the regression model showed no impact of age on the overall prediction of T2 GCOS scores, this difference in age had no impact on difference in change in empowerment between the groups studied.
| CONCLUSION
This is the first study of which we are aware to examine the effects of recurrence numbers on patient outcomes of genetic counseling. Our data challenge the notions that recurrence numbers should be routinely provided in genetic counseling, and show that optimal patient outcomes are not contingent on receipt of recurrence numbers, at least in a psychiatric setting. Future studies in other contexts where provision of recurrence numbers is driven by patient preference only would be valuable. Our data also support previous findings of the important positive patient outcomes of psychiatric genetic counseling, 4,10 and add to the growing body of work on genetic counseling outcomes, which will inform future evidence-based practice in clinical genetics.
